Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.33 USD
-0.05 (-3.62%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.33 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PACB 1.33 -0.05(-3.62%)
Will PACB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PACB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PACB
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
Here's Why You Should Add PacBio Stock to Your Portfolio Now
Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know
Other News for PACB
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
Commit To Buy Pacific Biosciences of California At $1, Earn 35% Using Options
PacBio (PACB) Technology Powers Significant Genomic Research in Arab Populations | PACB Stock News
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications | ...
PacBio HiFi sequencing used to power first Arab human pangenome